We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-7.76%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$295M
AUM Growth
-$57.6M
Cap. Flow
-$12.7M
Cap. Flow %
-4.32%
Top 10 Hldgs %
81.19%
Holding
63
New
3
Increased
2
Reduced
12
Closed
5

Top Buys

Rank Stock Value
1
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
+$8.86M
2
CXM icon
Sprinklr
CXM
+$3.16M
3
SANA icon
Sana Biotechnology
SANA
+$740K
4
QS icon
QuantumScape Corp
QS
+$346K
5
NNOX icon
Nano X Imaging
NNOX
+$37.8K

Top Sells

Rank Stock Value
1
SWI
SolarWinds Corporation Common Stock
SWI
+$6.38M
2
AFRM icon
Affirm
AFRM
+$4.39M
3
NABL icon
N-able
NABL
+$3.67M
4
MNDY icon
monday.com
MNDY
+$2.22M
5
HOOD icon
Robinhood
HOOD
+$2.1M

Sector Composition

Rank Sector Weight
1 Technology 56.94%
2 Consumer Discretionary 25.68%
3 Healthcare 9.49%
4 Energy 2.46%
5 Communication Services 2.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZUO
26
DELISTED
Zuora, Inc.
ZUO
$1.35M 0.46%
163,894
– –
PATH icon
27
UiPath
PATH
$6.52B
$1.32M 0.45%
76,949
-24,431
-24% -$407K
IAS
28
DELISTED
Integral Ad Science
IAS
$1.09M 0.37%
91,779
-5,000
-5% -$77.3K
U icon
29
Unity
U
$14B
$1.07M 0.36%
34,194
– –
DOCN icon
30
DigitalOcean
DOCN
$12.5B
$1.06M 0.36%
44,210
– –
DOCS icon
31
Doximity
DOCS
$3.89B
$1.06M 0.36%
49,804
– –
EB
32
DELISTED
Eventbrite
EB
$1.01M 0.34%
102,164
– –
FTCH
33
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$925K 0.31%
442,716
– –
PLRX icon
34
Pliant Therapeutics
PLRX
$65M
$857K 0.29%
49,434
– –
TWLO icon
35
Twilio
TWLO
$28.6B
$853K 0.29%
14,572
– –
DIBS icon
36
1stdibs.com
DIBS
$148M
$726K 0.25%
199,496
– –
GTM
37
ZoomInfo Technologies
GTM
$1.03B
$635K 0.22%
38,693
-77,831
-67% -$1.59M
HNST icon
38
The Honest Company
HNST
$412M
$599K 0.2%
475,629
– –
AFRM icon
39
Affirm
AFRM
$23.5B
$587K 0.2%
27,609
-240,458
-90% -$4.39M
PINS icon
40
Pinterest
PINS
$13.7B
$576K 0.2%
21,310
– –
IBRX icon
41
ImmunityBio
IBRX
$7.15B
$567K 0.19%
335,709
– –
SANA icon
42
Sana Biotechnology
SANA
$882M
$533K 0.18%
+137,694
New +$740K
HOOD icon
43
Robinhood
HOOD
$80.7B
$497K 0.17%
50,685
-189,499
-79% -$2.1M
QS icon
44
QuantumScape Corp
QS
$3.05B
$478K 0.16%
71,499
+42,548
+147% +$346K
CPNG icon
45
Coupang
CPNG
$27.2B
$456K 0.15%
26,834
– –
NEUE
46
DELISTED
NeueHealth
NEUE
$315K 0.11%
52,720
– –
DASH icon
47
DoorDash
DASH
$84.3B
$199K 0.07%
2,505
– –
PACB icon
48
Pacific Biosciences
PACB
$435M
$196K 0.07%
23,484
– –
RPTX
49
DELISTED
Repare Therapeutics
RPTX
$148K 0.05%
12,276
– –
OPEN icon
50
Opendoor
OPEN
$3.54B
$123K 0.04%
48,264
– –
1
2
3

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Harbourvest Partners held 63 positions worth $295M, down 16% from $352M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Harbourvest Partners withdrew a net $12.7M in Q3 2023, closing 5 positions and reducing 12 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $1.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 57% of assets, down from 57% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Harbourvest Partners opened a new position in Sprinklr worth $3.05M.

  • Harbourvest Partners's largest Q3 2023 buy was Sprinklr: 220,526 shares worth $3.05M.
  • Harbourvest Partners added most to Evelo Biosciences, Inc. Common Stock in Q3 2023, an estimated $8.86M increase.
  • Harbourvest Partners's biggest Q3 2023 reduction was SolarWinds Corporation Common Stock, cutting an estimated $6.38M.
  • Harbourvest Partners fully exited Sigilon Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $1.28M.
  • Harbourvest Partners's ten largest holdings make up 81% of its $295M portfolio in Q3 2023.
  • Harbourvest Partners opened 3 new positions and closed 5 in Q3 2023.
  • Harbourvest Partners's portfolio value fell 16% quarter-over-quarter to $295M.

Based on Harbourvest Partners's 13F filing for Q3 2023, filed 14 Nov 2023.